MedPath

Effect of losartan on intraocular pressure changes

Phase 3
Conditions
Intraocular pressure changing in hypertensive patients with normal IOP.
Registration Number
IRCT20210125050134N1
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
42
Inclusion Criteria

New HTN cases
Monotherapy with losartan

Exclusion Criteria

Glaucoma
Eye disease
Comorbidity diseae exept HTN
Myopia and hyperopia

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Intraocular pressure changing during 1 and 3 months. Timepoint: 0 , 1month ,3months. Method of measurement: Tonometry , Goldman Slit Lamp Tonometer.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath